While mRNA vaccines have received intense attention of late, another class of nucleic acid therapeutics has been ... While recouped R&D costs account for some of the cost, Wood notes that mass ...
hepatitis B, and non-alcoholic steatohepatitis. Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including mRNA, siRNA, replicon RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback